NKGN

Quote

Short

News

Articles

Message Board

NKGen Biotech Inc. (OTCMKTS : NKGN ) News

NKGen Biotech Inc. (OTCMKTS: NKGN) News Releases

NKGN News Releases

April 09, 2026 08:05:00 am

GlobeNewswire

NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer's and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit

March 23, 2026 08:05:00 am

GlobeNewswire

NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer's Disease at AD/PD 2026(TM)

March 10, 2026 08:05:00 am

GlobeNewswire

NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer's Disease at AD/PD(TM) 2026

January 22, 2026 08:05:00 am

GlobeNewswire

NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. to Scientific Advisory Board

December 03, 2025 08:05:00 am

GlobeNewswire

NKGen Biotech, Inc. Issues Statement on Recent Board Appointments at Majority-Owned Korean Affiliate NKGen Korea Co., Ltd.

October 09, 2025 08:05:00 am

GlobeNewswire

NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market

October 06, 2025 08:05:00 am

GlobeNewswire

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the XXVII World Congress of Neurology

October 02, 2025 07:00:31 am

US Earnings Reports

Expected US Company Earnings on Thursday, October 2nd, 2025

September 25, 2025 07:00:26 am

US Earnings Reports

Expected US Company Earnings on Thursday, September 25th, 2025

September 18, 2025 08:05:00 am

GlobeNewswire

NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account